Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Practice Membership
Public Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to Daniel C. Javitt
Patents Assigned to Daniel C. Javitt
Treatment of negative and cognitive symptoms of schizophrenia with glycine and its precursors
Patent number:
5854286
Abstract:
The amino acid glycine in an administered amount of above 0.4 g/Kg/day is used for treating symptoms of psychosis and of schizophrenia.
Type:
Grant
Filed:
December 6, 1996
Date of Patent:
December 29, 1998
Assignees:
Daniel C. Javitt, Stephen R. Zukin
Inventors:
Daniel C. Javitt, Stephen R. Zukin